OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly
| Autor: | Trainer, P.J., Newell-Price, J., Ayuk, J., Aylwin, S., Drake, W.M., Rees, A., Chanson, P., Brue, T., Webb, S.M., Fajardo, C., Aller, J., McCormack, A., Torpy, D.J., Tachas, G., Atley, L.M., Bidlingmaier, M. |
|---|---|
| Zdroj: | In Growth Hormone & IGF Research October 2014 24 Supplement 1:S21-S21 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect